Navigation Menu


Expected results

Design of kits and indexes (scores) related to the diagnosis and prognosis of physiological states related to the inflammatory state, obesity, nutritional quality (or adherence to a diet) and the predisposition to metabolic diseases. Likewise, kits for the personalization of therapeutic strategies.

  • Diagnostic and prognosis kits.

  • Kits of response or adherence to the diet.


Identification of new bioactive compounds useful in the control of body weight and the prevention of metabolic disorders:

  • Able to reduce or delay the digestion and absorption of macronutrients.

  • With antioxidant and anti-inflammatory properties.

  • With lipolytic activity, which directly affects the release of fatty acids from adipose tissue.

  • With inhibitory action on adipogenesis, avoiding the creation of new adipose tissue and its hypertrophy.

  • Able to increase energy expenditure, basal metabolism, thermogenesis and beiging of adipose tissue.


Identification of new bioactive compounds, combination of foods and dietary patterns capable of:

  • Able to reverse the dysbiotic states associated with obesity and metabolic disorders.

  • Able to modulate the epigenetic alterations that are involved in metabolic memory or are commonly observed in obesity and its complications.



Fermín Milagro Yoldi
Director of the Nutriomics and Biomarkers Project

General contact:
C/ Irunlarrea, 1
31008 Pamplona

+34 948 425600